AN2 Therapeutics Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
AN2 Therapeutics Inc
CIK #0001880438
EDGAR Form CIK 2011 - 2026
10-K [0001880438]
10-Q [0001880438]
3 [0001880438]
4 [0001880438]
8-K [0001880438]
D [0001880438]
SC 13D [0001880438]
SC 13G [0001880438]
Form 13D/13G Filer Form 13D/13G Subject Filed
Commodore Capital LP AN2 Therapeutics Inc [2026-03-16]
Integrated Core Strategies US LLC AN2 Therapeutics Inc [2026-03-13]
Vivo Opportunity Fund Holdings LP AN2 Therapeutics Inc [2026-03-13]
Almitas Capital LLC AN2 Therapeutics Inc [2026-02-17]
Almitas Capital LLC AN2 Therapeutics Inc [2025-11-14]
Coastlands Capital Partners LP AN2 Therapeutics Inc [2025-06-04]
BML Investment Partners LP AN2 Therapeutics Inc [2025-05-07]
BML Investment Partners LP AN2 Therapeutics Inc [2024-08-12]
Octagon Capital Advisors LP AN2 Therapeutics Inc [2024-07-03]
Frazier Life Sciences Public Fund LP AN2 Therapeutics Inc [2024-04-10]
View All
Form 3/4/5 Subject 2011 - 2026
AN2 Therapeutics Inc
Williams Sarah Joanne
Aziz Kabeer
Marks Gilbert Lynn
Martin Patricia A
Spigelman Melvin K
Easom Eric
Readnour Robin Shane
Day Lucy
Chanda Sanjay
FitzPatrick Margaret M
Wong Stephanie
Zakrzewski Joseph S
Eizen Joshua M
Prior Stephen David
Leonard Braden Michael
Shah Rajeev M
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II LP
RA Capital Management LP
Kolchinsky Peter
Krause Kevin Michael
Eckburg Paul
Adjuvant Capital Management LLC
Adjuvant Global Health Technology Fund LP
Adjuvant Capital GP LP
Adjuvant Global Health Technology Fund DE LP
Nazak Michael Adrian
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
2026-03-19 Disposed to issuer 50,150
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
2026-03-19 Disposed to issuer 23,742
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
2026-03-19 Disposed to issuer 10,362
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
2026-03-19 Grant 10,362
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
2026-03-19 Disposed to issuer 16,941
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
2026-03-19 Grant 23,742
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
2026-03-19 Grant 249,999
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
2026-03-19 Disposed to issuer 267,650
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
2026-03-19 Disposed to issuer 249,999
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
2026-03-19 Grant 225,000
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
2026-03-19 Disposed to issuer 225,000
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
2026-03-19 Grant 267,650
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
2026-03-19 Grant 23,742
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
2026-03-19 Disposed to issuer 20,724
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
2026-03-19 Grant 20,724
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
2026-03-19 Disposed to issuer 23,742
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
2026-03-19 Grant 16,941
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
2026-03-19 Grant 82,300
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
2026-03-19 Disposed to issuer 66,000
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
2026-03-19 Grant 66,000
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com